AF
BIIB icon

Alerus Financial’s Biogen BIIB Stock Holding History

Alerus Financial’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-768
Closed -$208K – 124
2017
Q2 		$208K Sell
768
-50
-6% -$13.2K 0.03% 122
2017
Q1 		$224K Sell
818
-61
-7% -$17.2K 0.03% 122
2016
Q4 		$249K Sell
879
-4,622
-84% -$1.37M 0.04% 116
2016
Q3 		$1.72M Sell
5,501
-4,213
-43% -$1.25M 0.28% 80
2016
Q2 		$2.35M Buy
+9,714
New +$2.56M 0.39% 69

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Alerus Financial's BIIB Position: Q3 2017 in Review

Alerus Financial sold out of Biogen (BIIB) in Q3 2017, closing a stake of 768 shares — an estimated $208K sold.

Alerus Financial first reported a position in BIIB in Q2 2016 and held it in 5 quarters. The position peaked at $2.35M in Q2 2016. 1,015 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.

  • Alerus Financial reported no remaining Biogen position as of Q3 2017 after selling out during the quarter.
  • Alerus Financial sold 768 Biogen shares in Q3 2017, an estimated $208K.
  • Alerus Financial first reported a position in Biogen in Q2 2016 and held it in 5 quarters.
  • Alerus Financial's Biogen position peaked at $2.35M in Q2 2016.
  • 1,015 funds tracked by Wall St. Rank held Biogen as of Q3 2017.

Based on Alerus Financial's 13F filing for Q3 2017, filed 13 Nov 2017.